NewAmsterdam Pharma pany N.V.-Wall Street Analysts Predict a 132.5% Upside in NewAmsterdam Pharma Company N.V. (NAMS): Here's What You Should Know

NewAmsterdam Pharma Company N.V. (NAMS) closed the last trading session at $18.37, gaining 21.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 42.71 indicates a 132.5% upside potential.The average comprises seven short-term price targets ranging from a low of $37 to a high of$ 52, with a standard deviation of $5.28. While the lowest estimate indicates an increase of 101.4% from ...